Triple Cardiovascular Disease Detection With an Artificial Intelligence-enabled Stethoscope

NAActive, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 25, 2023

Primary Completion Date

December 23, 2025

Study Completion Date

December 23, 2025

Conditions
Heart FailureHeart Valve DiseasesAtrial FibrillationHeart MurmursCongestive Heart FailureHeart Failure With Reduced Ejection Fraction
Interventions
DEVICE

AI-stethoscope

"Clinicians at practices in the intervention arm will be provided with one session of in-person training in use of the AI-stethoscope within 2 weeks of randomisation, including~1. Delivery and setup~2. Smartphone app installation and login~3. Pairing of all clinician smartphones with all AI-stethoscopes in the same practice~4. Demo of patient examination The AI-stethoscope will be used within its CE/UKCA-marked intended purpose. The clinical guidelines for use have been agreed by the NHS North West London Integrated Care System and Betsi Cadwaladr University Health Board Cardiovascular Executive Groups. Patients will be examined with the AI-stethoscope in accordance with these guidelines, and/or where stethoscope examination is deemed clinically appropriate. Patients will provide verbal consent for examination with the AI-stethoscope as per any physical examination performed by healthcare professionals for direct care, in accordance with UK law and General Medical Council guidelines."

Trial Locations (1)

Unknown

NHS North West London Integrated Care System, London

All Listed Sponsors
collaborator

Imperial College Health Partners

UNKNOWN

lead

Imperial College London

OTHER

NCT05987670 - Triple Cardiovascular Disease Detection With an Artificial Intelligence-enabled Stethoscope | Biotech Hunter | Biotech Hunter